Pleryon Pharmaceutics
Latest round
- Series A
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 2
About Pleryon Pharmaceutics
Founded in 2016 and based in Shenzhen, China, Pleryon Pharmaceutics is a biotech company that focuses on developing ophthalmic drugs. The founder of the company is Dr. Yu Yu. The company's main products include contact lens lubricant "PN-A001" on the elaSSTM platform and "PN-P001" long-acting anti-VEGF sustained-release gel based on the DynaMCTM platform. The company has a sustained-release drug platform based on microscopic pore size regulation, a polymer drug platform based on modular synthesis, and a nucleic acid delivery platform based on modular non-natural oligomers. Pleryon Pharmaceutics' revenue generates from out-licensing drug candidates, strategic partnerships, and eventual product commercialization. Additional income may come from veterinary therapeutics, ophthalmic formulations, and platform licensing.
Who invested in Pleryon Pharmaceutics
2 investors across 2 rounds
See all investors in Pleryon Pharmaceutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pleryon Pharmaceutics
Who invested in Pleryon Pharmaceutics?
Pleryon Pharmaceutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pleryon Pharmaceutics raised?
Pleryon Pharmaceutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pleryon Pharmaceutics last raise money?
Pleryon Pharmaceutics's most recent round on record is a Series A, in Aug 2025.
What does Pleryon Pharmaceutics do?
Founded in 2016 and based in Shenzhen, China, Pleryon Pharmaceutics is a biotech company that focuses on developing ophthalmic drugs.
Where is Pleryon Pharmaceutics headquartered?
Pleryon Pharmaceutics is headquartered in Shenzhen, China.
Which VCs invest in companies like Pleryon Pharmaceutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Pleryon Pharmaceutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pleryon Pharmaceutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.